Consensus Ventas, Inc. London S.E.

Stocks

0LO4

US92276F1003

Specialized REITs

Real-time Estimate Cboe BZX 18:04:21 22/09/2026 +04			5-day change	1st Jan Change
86.80 ^USD	+28.47%		-25.02%	-12.65%

09-21	Evercore ISI Adjusts Price Target on Ventas to $100 From $101, Maintains Outperform Rating	MT
09-16	Ventas, Inc. Announces Appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, Effective on or About October 5, 2026	CI

fb0.Aof2eUsvHEO-6h6fEHnoqje4WViucAgeKNVJwzA6Gk4.e8m7CgVGdnD1s27UQEii5l7VLxvhBWd5QuQrj2JXLyd24poOf0otLv-1Jg~908b86a5c830c68b21933e6777b024d0

Analysts' recommendations: Ventas, Inc.

09-21	Evercore ISI Adjusts Price Target on Ventas to $100 From $101, Maintains Outperform Rating	MT
09-02	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
09-02	JPMorgan Adjusts Price Target on Ventas to $104 From $94, Maintains Overweight Rating	MT
09-01	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
08-31	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
08-14	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
08-14	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
08-12	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
08-11	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
08-05	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
08-04	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
08-03	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
08-03	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
07-30	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
07-24	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
07-22	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
07-15	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
07-10	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
07-01	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
06-18	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
06-16	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
06-01	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
05-26	BofA Adjusts Price Target on Ventas to $110 From $102	MT
05-22	Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating	MT
05-22	Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating	MT

More recommendations

Healthcare REITs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	WELLTOWER INC.					+12.58%
	VENTAS, INC.					+16.99%
	OMEGA HEALTHCARE INVESTORS, INC.					+10.8%
	HEALTHPEAK PROPERTIES, INC.					+10.75%
	AMERICAN HEALTHCARE REIT, INC.					+23.14%
	CARETRUST REIT, INC.					+19.84%
	AEDIFICA					+25.84%
	HEALTHCARE REALTY TRUST INCORPORATED					+17.22%
	SABRA HEALTH CARE REIT, INC.					+14.67%
	Average					+16.87%
	Weighted average by Cap.					+14.23%